Shuling Chen
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 5%
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
Papers in
- Hepatology 33
- Hepatocellular Carcinoma Treatment and Prognosis 33
- Surgery 21
- Cholangiocarcinoma and Gallbladder Cancer Studies 10
- Pediatric Hepatobiliary Diseases and Treatments 4
- Co-authors
- Ming Kuang (37 shared papers)Kaiyu Sun (12 shared papers)Jianbo Xu (4 shared papers)Yulong He (2 shared papers)Sui Peng (26 shared papers)Guanghua Li (2 shared papers)Zhenwei Peng (27 shared papers)Xiaoyan Xie (17 shared papers)
- Journals
- European Radiology (8 papers)Hepatology (4 papers)BMC Cancer (4 papers)Frontiers in Oncology (4 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Shuling Chen
103 papers receiving 3.1k citations
Shuling Chen's Hit Papers
Peers
Comparison fields: 5 of 116
- Hepatology 910
- Oncology 592
- Cancer Research 318
- Health Informatics 29
- Radiology, Nuclear Medicine and Imaging 455
Countries citing papers authored by Shuling Chen
This map shows the geographic impact of Shuling Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuling Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuling Chen more than expected).
Fields of papers citing papers by Shuling Chen
This network shows the impact of papers produced by Shuling Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuling Chen. The network helps show where Shuling Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Shuling Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 346 | |
| 2 | 2019 | 163 | |
| 3 | 2018 | 156 | |
| 4 | 2019 | 143 | |
| 5 | 2022 | 125 | |
| 6 | 2019 | 125 | |
| 7 | 2021 | 103 | |
| 8 | 2015 | 77 | |
| 9 | 2021 | 65 | |
| 10 | 2018 | 65 | |
| 11 | 2018 | 64 | |
| 12 | 2018 | 61 | |
| 13 | 2022 | 60 | |
| 14 | 2019 | 60 | |
| 15 | 2020 | 59 | |
| 16 | 2014 | 59 | |
| 17 | 2021 | 48 | |
| 18 | 2018 | 47 | |
| 19 | 2022 | 46 | |
| 20 | 2016 | 43 |
About Shuling Chen
Shuling Chen is a scholar working on Hepatology, Surgery, Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 110 papers that have together received 3.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (33 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Radiomics and Machine Learning in Medical Imaging (7 papers), Gastric Cancer Management and Outcomes (5 papers), Inflammatory Bowel Disease (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Pediatric Hepatobiliary Diseases and Treatments (4 papers) and Cancer Mechanisms and Therapy (3 papers). The work is most often cited by research in Hepatology (910 citations), Oncology (592 citations), Cancer Research (318 citations), Health Informatics (29 citations) and Radiology, Nuclear Medicine and Imaging (455 citations). Shuling Chen has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Ming Kuang, Kaiyu Sun, Jianbo Xu, Yulong He, Sui Peng, Guanghua Li, Zhenwei Peng, Xiaoyan Xie, Wei Wang and Shi‐Ting Feng. Their work appears in journals such as European Radiology, Hepatology, BMC Cancer, Frontiers in Oncology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.